arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Journey Medical Corp

DERM
$6.41 ▼ -0.12 (-1.84%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
25 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

Journey Medical Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $175.0M
Dividend Yield
Revenue Growth 21.5%
Op. Margin -9.3%
ROIC -2.1%
FCF / Share $0.11
Trailing P/E
Price / Book 5.7x
FCF Yield 1.7%
Debt / Equity 0.82
info Valuation on last close. End-of-day price, Aug 7, 2026.

25-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$15.96M
↑ +21.5%
Net Income Profit after all expenses
$-2.23M
↑ +45.2%
Operating Margin Operating profit as % of sales
-9.3%
↓ -239.3% 13th
FCF / Share Free cash flow per share
$0.11
↑ +211.6%
Long-Term Debt Long-term obligations
$25.37M
— +0.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
11
Returns
21
Financial Health
39
Cash Quality
69

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 25 quarters